Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. - Wikidata - awgldk - TriplyDB

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

http://www.wikidata.org/entity/Q35087552

about

Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers Microstructural alterations of sputum in cystic fibrosis lung disease.Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm.Nanoparticle diffusion in respiratory mucus from humans without lung disease.PEGylation as a strategy for improving nanoparticle-based drug and gene delivery Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis.Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues.A Potential Application of Canaloplasty in Glaucoma Gene Therapy Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.Self-folding polymeric containers for encapsulation and delivery of drugs.When are we operating for chronic rhinosinusitis? A systematic review of maximal medical therapy protocols prior to endoscopic sinus surgery.Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination.Challenges in nasal drug absorption: how far have we come?From the Cover: Comparative Numerical Modeling of Inhaled Nanoparticle Deposition in Human and Rat Nasal Cavities.In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.Drug-eluting nasal implants: formulation, characterization, clinical applications and challenges.Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.Health state dependent multiphoton induced autofluorescence in human 3D in vitro lung cancer model.Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery.Nanoparticle filtering in charged hydrogels: Effects of particle size, charge asymmetry and salt concentration.Strategies and industrial perspectives to improve oral absorption of biological macromolecules.Physicochemical properties of mucus and their impact on transmucosal drug delivery.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.ZMappTM Reinforces the Airway Mucosal Barrier Against Ebola Virus.Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers.

P2860

Q26823541-1A63F74E-938C-4796-AF43-39AE83C8AE8C Q28486428-BD2B0CF4-E794-4113-A077-8CCA290ACCBC Q30546346-C000B705-0D42-4165-A106-D1C999592430 Q30826846-CA781ECF-6A02-4716-8E8E-F1ABC582CA53 Q30844270-FC58E220-1D9F-42E3-87AC-CBBF8F1F6673 Q35678511-0D58FF75-CDED-4320-97E7-DAAF0D1F4BA7 Q36664260-95A517E8-9B35-4F80-AFE8-50DCC5F34358 Q36703361-455C6302-595F-4FBC-B8C5-503EB8657807 Q36961634-17ACA5E9-F366-49D7-9ED5-7F9FA889E623 Q36984496-542E6C19-7B36-42A8-9B31-866D90E31067 Q37011581-EEC569B1-F523-48D6-855F-4735C6331995 Q37033060-E2C880E1-C68F-4B97-B8DF-E541ED3B3704 Q37062353-2F9D3A2B-9D91-4145-85C9-52D9AFCACDE1 Q37571900-E61F87C6-969C-4B7D-81D0-55D52724CAE0 Q37633436-C3101677-FF0F-4FBE-857B-099D8AF1BA8A Q37994472-92A48477-973B-4115-96B6-B912EE680AA9 Q38552185-E1E37785-7301-4DC7-8615-8D935BC52783 Q38702368-4FD17B0C-CAB7-4C03-9BE1-54AAC5AE1263 Q38842805-FB731F64-1203-4F5E-853D-B16B0C1842D9 Q38864445-3F777A2D-DED7-4EAA-9AF8-F4DF93456CCE Q38905471-254041B4-B58A-42D9-B068-7C67FAE00DD7 Q39185164-6F35E18F-D66E-4397-976E-9247476E22D2 Q41587469-7D1DA99E-0AA4-4AC4-A83C-048BC13C01CD Q42761110-E54E00E8-0B79-4133-BC19-DFD3871BE0B6 Q45023809-79CBE847-9E50-4903-929B-19F36EA0E06D Q46700387-C3D2540F-F8F5-4BAA-8A41-3842D978A513 Q47128587-425F107A-B59C-4AE0-9CD4-529C710EB2C0 Q47244850-225FDC92-E188-4C17-BF84-16EB9E190930 Q47304860-81624642-D959-4C44-A85B-DE37AEA362E8 Q47431381-781122F8-3510-4751-B787-C7A98C89D960 Q47791593-09AD15CE-D661-4325-9213-458DB37899B4 Q52654049-C43E7BFE-2A7C-44DB-96FE-A751B4921A7C Q54107825-83372A6D-FB73-4DF1-8C1E-4B839C34D663 Q55448277-1FAD71B9-5F73-43E4-94A1-2E3F03030852

P2860

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

http://www.wikidata.org/entity/Q35087552

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@ast

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@en

type

label

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@ast

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@en

prefLabel

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@ast

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@en

P1433

Q35087552-5429D084-B066-4F84-8785-DE1E4A7236D2

P1476

Q35087552-0352018D-8839-4536-B94D-F8124C4F65FF

P2093

Q35087552-5A2896FE-9D7B-4059-96F3-18E594B6C5EC

Q35087552-5C26D4E2-604D-40AD-A97D-7899D0F50F62

Q35087552-81ACE779-7D9F-4C59-A3EE-0A118B6A6732

Q35087552-9998BBA8-4C5A-49C4-82DD-96EB902F97FC

Q35087552-BE26E544-70EC-4C7B-B996-E974D438DA96

Q35087552-DF48B728-921B-470F-B563-BA344A1F1791

Q35087552-E0735C6D-3370-4533-828C-C7EF399836BA

Q35087552-EA84B367-5FF0-4DAE-9472-66F835185313

P2860

Q35087552-015675E3-1C65-467C-BB8C-396D4A58CF10

Q35087552-017C7784-3864-49B4-98EB-CDE8A37CA321

Q35087552-0D9B1A37-473E-4722-B7EA-4575A0BFFFC5

Q35087552-1E71E786-C9C4-4D81-A7C0-6AA0470EE182

Q35087552-3230FCDE-C490-495D-928E-204D0B88BAD5

Q35087552-35CAF7A4-19B7-4B1B-B54D-E5D720A61036

Q35087552-38827F0F-9EDA-4BBD-95DD-52CC3FC06C72

Q35087552-3AA1FD65-5027-48AE-A5E3-E772C9AA0CFE

Q35087552-3E06C886-441E-496F-B2A0-78037C0C9714

Q35087552-412DB09B-1B88-4FE0-A100-63AF666B9630

P304

Q35087552-552EDA2F-A45C-4250-BC2F-CC39AD776D8D

P31

Q35087552-65F0BD95-B7EA-4249-B341-99B8265171FE

P356

Q35087552-E1830061-5A7C-45FD-BCAB-3DDC1C1158B3

P433

Q35087552-D3F5CCD5-8DCD-40F6-8E3C-7722F0DEA1AD

P478

Q35087552-2F170D53-5DC8-4723-812E-1339F995561A

P50

Q35087552-CBF04AB9-05F8-4FF9-8F9F-DF1EFFEE35BF

P577

Q35087552-89BF1333-6E40-4D01-8920-6DDE61DF0783

P5875

Q35087552-92274AAD-A37E-419C-B8F6-7222E9DF40EF

P698

Q35087552-3DDE4D0C-6E01-400C-9219-CC367A389BE9

P921

Q35087552-C5231FD6-A402-4E4E-A36F-8C5816F11129

Q35087552-E7C0D82F-2FE4-4C8F-A936-6D07684BE912

P932

Q35087552-E94A2BF3-3791-4F72-9F10-AA2FF598E3D7

P356

J.BIOMATERIALS.2011.05.008

P1433

P1476

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

@en

P2093

Amanda Pace

http://www.w3.org/2001/XMLSchema#string

Jean Kim

http://www.w3.org/2001/XMLSchema#string

Jeane Chen

http://www.w3.org/2001/XMLSchema#string

Jung Soo Suk

http://www.w3.org/2001/XMLSchema#string

Ming Yang

http://www.w3.org/2001/XMLSchema#string

Olcay Mert

http://www.w3.org/2001/XMLSchema#string

Samuel K Lai

http://www.w3.org/2001/XMLSchema#string

Ying-Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Micro- and macrorheology of mucus

Altering mucus rheology to"solidify" human mucus at the nanoscale

Small-scale systems for in vivo drug delivery

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies

Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.

Biodegradation and biocompatibility of PLA and PLGA microspheres.

Diffusion of macromolecules and virus-like particles in human cervical mucus

Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.

P304

6285-6290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2011.05.008

http://www.w3.org/2001/XMLSchema#string

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51211663

http://www.w3.org/2001/XMLSchema#string

P698

21665271

http://www.w3.org/2001/XMLSchema#string

P921

P932

3130096

http://www.w3.org/2001/XMLSchema#string